Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial

INTRODUCTION: Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening skin disease. The global Effisayil 1 study investigated the efficacy and safety of spesolimab, a humanized monoclonal antibody targeting the IL-36 receptor, in patients experiencing GPP flare. This analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Tsen-Fang, Zheng, Min, Ding, Yangfeng, Song, Zhiqi, Liu, Quanzhong, Chen, Ying, Hu, Hanzhao, Xu, Jinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689646/
https://www.ncbi.nlm.nih.gov/pubmed/37840119
http://dx.doi.org/10.1007/s13555-023-01037-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689646/
https://www.ncbi.nlm.nih.gov/pubmed/37840119
http://dx.doi.org/10.1007/s13555-023-01037-4

Ejemplares similares